Dinucleoside polyphosphates comprises a group of dinucleotides formed by two nucleosides linked by a variable number of phosphates, abbreviated NpnN (where n represents the number of phosphates). These compounds are naturally occurring substances present in tears, aqueous humour and in the retina. As the consequence of their presence, these dinucleotides contribute to many ocular physiological processes. On the ocular surface, dinucleoside polyphosphates can stimulate tear secretion, mucin release from goblet cells and they help epithelial wound healing by accelerating cell migration rate. These dinucleotides can also stimulate the presence of proteins known to protect the ocular surface against microorganisms, such as lysozyme and lactoferrin. One of the latest discoveries is the ability of some dinucleotides to facilitate the paracellular way on the cornea, therefore allowing the delivery of compounds, such as antiglaucomatous ones, more easily within the eye. The compound Ap 4 A has been described being abnormally elevated in patient's tears suffering of dry eye, Sjogren syndrome, congenital aniridia, or after refractive surgery, suggesting this molecule as biomarker for dry eye condition. At the intraocular level, some diadenosine polyphosphates are abnormally elevated in glaucoma patients, and this can be related to the stimulation of a P2Y 2 receptor that increases the chloride efflux and water movement in the ciliary epithelium. In the retina, the dinucleotide dCp 4 U, has been proven to be useful to help in the recovery of retinal detachments. Altogether, dinucleoside polyphosphates are a group of compounds which present relevant physiological actions but which also can perform promising therapeutic benefits.
1. Introduction
Dinucleoside polyphosphates: structure and features
Dinucleoside polyphosphates are a family of dinucleotides related to others such as nicotinamide adenine dinucleotides (NAD and NADP), but slightly different in their structure. Dinucleoside polyphosphates comprise all those dinucleotides formed by two nucleosides bridged by a variable number of phosphates. The two nucleosides moiety can be formed by ribose which may present the same or different bases, either purines or pyrimidines (Fig. 1) . Although in theory the possibilities of dinucleotides are enormous, simply by combining the nitrogenised bases and the phosphate length, there are only a few which have been recognised as naturally occurring dinucleoside polyphosphates, nonetheless, other dinucleoside polyphosphates have been synthesised either enzymatically or chemically (Guranowski et al., 1995; Mizuno and Sasaki, 1965; Ortiz et al., 1993) . Dinucleoside polyphosphates can be named in different ways, for instance, a, u dinucleoside polyphosphates, dinucleoside 5 0 , 5 000 -P 1 , P n polyphosphates or Np n N. The latter is the most common one in which "N" is substituted by the bases (A, G, U, for example) and "n" by the number of phosphates. Dinucleoside polyphosphates found in biological systems are those formed by two adenosines, which are termed diadenosine polyphosphates, Ap n A, the ones formed by guanosines, diguanosine polyphosphates, Gp n G, or a combination of both, one moiety with adenosine and the other with guanosine (Gp n A). Concerning the phosphate length linking both nucleosides, this can vary from two to seven, although the most common are those dinucleotides with 3e5 phosphates. Common, naturally occurring dinucleoside polyphosphates, according to the number of phosphates, are Ap 5 A or Gp 4 G.
Synthetic dinucleoside polyphosphates are relevant since they depict remarkable actions on ocular physiology (Guzman-Aranguez et al., 2007 , 2011 . Among these the ones with uridine, diuridine polyphosphates (like Up 4 U AKA diquafosol), with deoxycytidine and uridine (dCp 4 U, also termed denufosol), or those with hypoxanthine, diinosine polyphosphates (Ip n I), have demonstrated interesting therapeutic properties in the eye as it will later be described (Fujihara et al., 2001; .
The history of dinucleoside polyphosphates started far away from the future physiological and pharmacological applications found in the eye. Indeed, the first news on these molecules occurred in the 1960's. Dinucleoside polyphosphates were discovered in the eggs of brine shrimps, mostly diguanosine polyphosphates (Finamore and Warner, 1963; Warner, 1964) . These dinucleotides are the basis for the development of the eggs into proper shrimps since they will be used for DNA synthesis.
It was not until a few years later when it was possible to identify a biochemical reaction showing the synthesis of a dinucleoside polyphosphate. Scientists, when investigating the reaction between aminoacids and their corresponding tRNAs during the protein synthesis process discovered the presence of some diadenosine polyphosphates Zamecnik et al., 1966) . Over the following years, most of the efforts were dedicated to describing their structural and chemical properties, mainly by spectrometric methods (Bush and Tinoco, 1967; Cheng, 1968; Warshaw and Tinoco, 1965) . Changes in the molecules present were also studied when environmental properties (Lee et al., 1979) such as temperature or pH was modified (Chan and Nelson, 1969; Davis and Tinoco, 1968; Glaubiger et al., 1968; Hruska and Danyluk, 1968; Ikehara et al., 1970; Rabczenko and Shugar, 1971; Ts'o et al., 1969) . The structural changes are especially relevant when the pH medium is altered. The structure of a Np n N, for example, Ap 4 A, under physiological pH condition (pH z 7), depicts a stacked conformation in which the adenine rings are piled up, this being possible due to the phosphate chain folding. This is caused by the negatively charged phosphate groups and the partially positively charged adenine rings and the consequent electrostatic interactions. A different panorama is observed when the pH lowers (pH z 4). Under this condition the phosphates are folded but the adenine rings are pointing to opposite directions. The maximal open possible conformation is reached at a pH below 3. Under this condition the protonation of the phosphates occurs and the interactions among the adenines and phosphates do not exist .
The conformational changes observed at different pH, may explain why these dinucleotides can interact with different purinergic receptors, mainly when in some environmental conditions, such as acidic synapses (glutamatergic) the conditions can be far from neutral conditions (Gualix et al., 2003) .
Concerning temperature, it seems that dinucleoside polyphosphates at low temperatures present their bases in a stacking conformation being so close to each other that there is no room for water between them. On the contrary, when temperature is high, even at denaturing conditions (above 40 C), the bases are not stacked and they do not interact with each other and therefore can interact with the solvent and other molecules. In this case, the only limitation of the aromatic bases would be their covalent bonds to the respective riboses (Davis and Tinoco, 1968; Glaubiger et al., 1968) .
Presence and actions of dinucleoside polyphosphates

Presence and intracellular actions of dinucleoside polyphosphates
It took quite a long time from the moment these dinucleotides were identified until some biochemical and physiological actions for these compounds were detected. One of the first actions was the effect of diadenosine tetraphosphate, Ap 4 A, on DNA polymerase triggering DNA replication (Grummt, 1978 (Grummt, , 1979 Grummt et al., 1979) . Indeed, it has been possible to correlate changes (increases) in Ap 4 A concentrations during the cell cycle and specially during cell proliferation and DNA synthesis (Bambara et al., 1985) . These experiments were quite controversial, although other authors could, in part, confirm the relationship between Ap 4 A and DNA synthesis, it seemed that apparently the dinucleotide would prime DNA synthesis rather than activating the polymerase (Zamecnik et al., 1982) . Also, some other studies suggested a close relation between the amino acid activation process and DNA replication in mammalian cells (Grummt, 1983; Rapaport et al., 1981) .
Another intracellular action suggested for dinucleoside polyphosphates has been its possible role of "alarmone" (Lee et al., 1983; Varshavsky, 1983 ). An alarmone is a molecule that reflects and indicates a stress situation within a cell. A classical situation is that in which an elevation of temperature, apart from increasing the levels of heat shock proteins (HSPs), also produces a rise in dinucleoside polyphosphates such as Ap 3 A, Ap 4 A, Gp 4 A and Gp 3 A (Lee et al., 1983) . The same dinucleotides are increased when cells are submitted to oxidative stress in a process independent from the dinucleotide synthesis by aminoacyl-tRNA synthetases.
Presence and extracellular actions of dinucleoside polyphosphates
Although the presence and actions of dinucleoside polyphosphates have been reported in several tissues as indicated (Andersson, 1989; Rapaport and Zamecnik, 1976; Ripoll et al., 1996) , two sources are relevant concerning the eye physiology: the blood vessels and the nervous system.
Apart from the presence of dinucleoside polyphosphates in crustaceans as previously indicated, these molecules were found as putative active vasoactive compounds when they were discovered in platelet secretory granules (Flodgaard and Klenow, 1982; Luthje and Ogilvie, 1983) . From the moment they were discovered the main interest of the scientific community was to identify those actions triggered by the dinucleotides in the blood stream. In this sense, one of the first roles was their involvement in platelet aggregation. Interestingly, the two dinucleotides contained in the platelets (in their dense granules), Ap 3 A and Ap 4 A, depicted opposite actions; while the first was inducing platelet aggregation, the second, showed disaggregating properties (Luthje et al., 1985) . Nonetheless, the existence of dinucleoside polyphosphates in the plasma and blood (Luthje and Ogilvie, 1988) , also suggested an effect on vasoconstriction or/and vasodilation. When analysing the effect of the vascular tone, dinucleoside polyphosphates such as Ap 4 U produces a biphasic effect although the predominant one at low concentrations is vasoconstriction, infusions of this dinucleotide elicit hypotension and electrolyte retention (Flores et al., 1999; Hansen et al., 2010) .
The identification of dinucleoside polyphosphates and mainly diadenosine polyphosphates in neural secretory vesicles showed the storage of these dinucleotides with classical transmitters such as noradrenalin (Rodriguez del Castillo et al., 1988) . This colocalization was further extended to cholinergic and monoaminergic synaptic vesicles (Miras-Portugal et al., 1998 , 1999 Pintor et al., 1992 ). Moreover, it was possible to demonstrate that these dinucleotides were releasable in a Ca 2þ dependent manner from brain synaptic terminals (Pintor et al., 1991 (Pintor et al., , 1992 and also by the effect of drugs such as amphetamines (Pintor et al., 1993) . The role of diadenosine polyphosphates, mainly Ap 4 A and Ap 5 A in the nervous system has been the modulation of the release of monoamines (Giraldez et al., 2001) , glutamate (Gualix et al., 2003) , or the inhibition of synaptic transmission in the hippocampus (Klishin et al., 1994 ).
Purinergic receptors and dinucleoside polyphosphates
Extracellular actions of dinucleoside polyphosphates occurred by means of receptors on the cell surface termed P2 purinergic receptors. These types of receptors are divided into two families, the P2X ionotropic (Habermacher et al., 2015) and the P2Y metabotropic receptors (von Kugelgen and Harden, 2011) . P2X receptors are activated by nucleotides and dinucleotides which mediate the rapid and non-selective cation transients (mainly Na þ and Ca 2þ ) from the extracellular space (Samways et al., 2014) , causing depolarization of the membrane ion channels and subsequent activation of voltage dependent calcium channels. Seven members of P2X receptors in mammalians have been cloned (P2X1-P2X7) and they combined various forms of these subunits (Saul et al., 2013) . Cloning of P2X receptors has revealed that all the subunits have large extracellular loop with ten cysteine residues, two transmembrane domains and short intracellular C and N terminals (Roberts et al., 2006) . Three subunits are necessary to form a functional native channel, and these channels are organized as homotrimers or heterotrimers (Coddou et al., 2011) . P2Y receptors are metabotropic receptors, members of the family of G protein-coupled receptors containing seven hydrophobic transmembrane domains connected by three extracellular loops and three intracellular loops, with an extracellular N-terminal end and another C-terminal oriented intracellularly (Jacobson and Boeynaems, 2010) . These receptors are coupled, via G proteins to others, such as phospholipase C (PLC), adenylate cyclase or to ion channels (von Kugelgen and Hoffmann, 2015 . The other group includes the P2Y 12 , P2Y 13 and P2Y 14 receptors, associated with Gi proteins and inhibiting adenylate cyclase. The P2Y 11 is the only thing that can be coupled to both Gs and Gq proteins (Jacobson et al., 2015) .
Concerning the action of dinucleoside polyphosphates and the activation of P2 receptors, most of the research has been carried out for Ap n A compounds (Hoyle et al., 2001) . In this sense, diadenosine polyphosphates can activate all the P2X receptors (Wildman et al., 1999) , including the heteromeric P2X2/3. It is noteworthy to indicate that the most active dinucleotide has been Ap 4 A in most cases. (Pintor and Miras-Portugal, 1995b) . Also, the P2X7 was only sensitive to these dinucleotides at concentrations above 1 mM, this effect being far from the physiological concentrations of these compounds.
Regarding the P2Y receptors, P2Y 1 and P2Y 2 are the ones that are stimulated by diadenosine polyphosphates (Patel et al., 2001 ). The tandem Ap 4 A-P2Y 2 is of special interest since it participates in many physiological processes in many ocular structures ( Fig. 2 see  below) .
Dinucleoside polyphosphate degradation
The concentration of dinucleoside polyphosphates is tightly regulated by a variety of enzymes, mainly hydrolases that are present in all organisms and generally act on the polyphosphates
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G. Carracedo et al. / Progress in Retinal and Eye Research xxx (2016) 1e24 chain of these molecules. The enzymes involved in the catabolism of dinucleoside polyphosphates have been reviewed by Guranowski (Guranowski, 2000) . Extracellular dinucleotides, which regulate physiological processes via P2 receptors activation, are degraded principally by ectonucleotide pyrophosphatase/phosphodiesterases (NPPs) (Asensio et al., 2007; Vollmayer et al., 2003) . This family of enzymes are hydrolases located on cell surface and are a type of the so called ecto-nucleotidases (Zimmermann et al., 2012) . In vertebrates, NPPs have seven members (NPP1eNPP7) but only three (NPP1eNPP3) can degrade nucleotides (dinucleotides but also nucleoside triphosphates and diphosphates) (Goding et al., 1998; Jin-Hua et al., 1997; Stefan et al., 1999) . Dinucleotides degradation by NPPs produce nucleoside monophosphates (NMP) plus nucleoside polyphosphates (NP nÀ1 ). Therefore, NPPs can generate metabolites biologically active such as ADP and ATP that are obtained from the naturally occurring diadenosine polyphosphates (Vollmayer et al., 2003; Zimmermann, 2000) . These nucleotides can also be degraded by NPPs and essentially through ecto-nucleoside triphosphate diphosphohydrolases (NTPDases), other family of ecto-enzymes that can degrade nucleoside triphosphates and diphosphates (Zimmermann, 1999) .
On the other hand, the degradation of diadenosine polyphosphates and their metabolites ATP as well as ADP produce AMP. This nucleoside monophosphate can also be catabolized through ecto-5 0 -nucleotidase (eN) as well as alkaline phosphatase enzymes (this last ecto-nucleotidase may also act on ATP and ADP molecules) (Zimmermann et al., 2012) . Consequently, AMP is converted into the nucleoside adenosine, which mediates purinergic effects via P1 receptors interaction (Jacobson and Gao, 2006) .
Finally, extracellular adenosine can be eliminated from the synaptic cleft through cell surface adenosine deaminases that convert adenosine to inosine and/or nucleoside transporters (Bonan, 2012; Franco et al., 1997; Pastor-Anglada and Perez-Torras, 2015) . These transporters, equilibrative and concentrative nucleoside transporters, are integral membrane proteins implicated in the cellular uptake of adenosine (Bonan, 2012; Pastor-Anglada and Perez-Torras, 2015) .
Dinucleoside polyphosphates in the eye
Ocular surface
The ocular surface is the outer zone of the eye. It is a functional unit composed of different structures such as corneal and conjunctival epithelium, lacrymal glands, eyelids and tear film. All components of this functional unit are linked through the innervation and vascular immunologic and endocrine systems. The main functions of the ocular surface are to maintain the transparency of the cornea (optic quality issues) and to hydrate and protect the corneal and conjunctival epithelium to the external agents. The tear film is mainly in charge of these functions. It is critical to have a correct volume and stability of the tear film to maintain the integrity of the ocular surface. The loss of the ocular homeostasis provokes serious clinical manifestations as a dry eye, infections of epithelial defects (Gipson, 2007; Knop and Knop, 2007; Paulsen, 2008) .
The ocular structure that has probably been investigated in more depth regarding dinucleoside polyphosphates is the ocular surface and specially the tear film. The presence of diadenosine polyphosphates in the tear film has been noted in different conditions and also the different purinergic receptors in the ocular surface that can be activated by the dinucleotides (GuzmanAranguez and . Moreover, the effects of the ocular surface of different dinucleotides when these compounds are instilled on the ocular surface have also been previously described . In the following sections, the presence and effect of dinucleoside polyphosphates will be reviewed.
2.1.1. Purinergic receptors in the ocular surface P2X and P2Y receptors are expressed in different zones of the ocular surface, the P2Y 2 subtype being the most abundant, identified in the corneal and conjunctival epithelium, corneal endothelium and main lacrimal gland (Pintor et al., 2004b) . All P2 purinergic receptors described in the ocular surface and their functions are summarized in Table 1 . The expression of P2 receptors in different ocular surface locations suggests the involvement of these receptors in the physiology of the eye (Guzman-Aranguez and . In fact, during the last decade, the role of several nucleotides and their receptors in ocular processes, including tear secretion (through P2Y 2 receptor) (Jumblatt and Jumblatt, 1998; Murakami et al., 2000) , corneal wound healing (P2Y 2 is able to accelerate the corneal re-epithelization and proliferation, meanwhile P2Y 6 inhibits the process) (Byun et al., 2016; Crooke et al., 2009; Mediero et al., 2006) , and corneal epithelial migration and stromal organization (mediated through P2X7 receptor) have been described (Mankus et al., 2012; Mayo et al., 2008) .
Action of ectodinucleotidases in the ocular surface
As we mentioned above, the dinucleotides effects on ocular surface are due mainly to Ap 4 A and Ap 5 A but also their metabolites such as ATP and adenosine and the ecto-nucleotidases, mainly NPPs, control the availability of these extracellular dinucleotides and their metabolites. In this context, the expression of some ectoenzymes has been detected, including ENPP1 as well as ENPP3 isoforms, NTPD1 isoform and 5NTE in human conjunctival cells obtained by impression cytology (see Fig. 3 ). Regarding adenosine, ocular surface also present ecto-adenosine deaminases and nucleoside transporters that can control its possible effects (Majumdar et al., 2003; O'Brien et al., 1987) .
The existence of conjunctival NPP isoenzymes ( Fig. 3 ) with different substrate specificity might explain, together with the nonneuronal origin of Ap 4 A and Ap 5 A, the different concentration of these dinucleotides in tear. Nevertheless, Vollmayer and colleagues have proved that NPP1 and NPP3 hydrolyze Ap 4 A as well as Ap 5 A with similar rates (Vollmayer et al., 2003) .
Presence in the tear film of healthy patients
The presence of diadenosine polyphosphates in the tear film was studied due to their properties to enhance both tear secretion and to increase the wound healing rate (Guzman-Aranguez et al., 2007 , 2011 Pintor et al., 2004a; Pintor et al., 2002b) . The exogenous addition of these dinucleotides suggested their presence as natural constituents of tears.
When investigating dinucleotides in tears, this fluid was extracted by using paper strips to perform the Schrimer test (for tear volume measurement), placed in the inferior lid margin of the eye for 5 min (van Bijsterveld, 1969) . The strips were then processed to be evaluated by High Pressure Liquid Chromatography (HPLC), following the procedure described by Pintor et al. (Pintor et al., 1992) . The first adenine dinucleotides described in tear were Ap 4 A and Ap 5 A, which were found in New Zealand rabbit tears (Pintor et al., 2002b) . Diadenosine tetraphosphate concentration was 2.92 ± 0.28 mM and diadenosine pentaphosphate concentration was 0.587 ± 11 mM. These concentrations would be enough to activate the ocular surface P2 receptors.
Initially, the hypothesis of the release of these dinucleotides in rabbit tear film was thought to occur via the exocytotic release from the nerve terminals present on the ocular surface, since this mechanism has been described for these dinucleotides in the central nervous system (Pintor et al., 2002a) . However, when the ocular denervation was performed in rabbits, the release of these dinucleotides was similar to non-denervated animals, indicating that the delivery was not from the nerve terminals by a Ca 2þ independent mechanism in the CNS (Guzman-Aranguez et al., 2007) . The mechanism for the dinucleotide release in the ocular surface was studied in humans. The first study confirmed the presence of diadenosine polyphosphates in the human tear film (Pintor et al., 2002a) . The presence of Ap 4 A and Ap 5 A was found, as in rabbit model, and it was possible to measure small levels of Ap 3 A. In human tears, the levels of diadenosine polyphosphates are 2.1 ± 2.2 nM, 108.7 ± 18.3 nM, and 37.1 ± 6.2 nM for Ap 3 A, Ap 4 A, and Ap 5 A, respectively. The concentrations of diadenosine polyphosphates in rabbits were one order of magnitude higher than that found in humans, but the Ap 4 A/Ap 5 A ratio in rabbits and humans was almost identical, with ratios of 2.97 and 2.91, respectively. In addition, ATP seems to be present in tears contributing to the nucleotide pool present in tears, therefore modulating some physiological processes on the eye surface. Srinivas and co-workers found that its presence in tears is a consequence of shear stress induced on the corneal epithelial cells in cultured rabbit corneal epithelial cells model (Srinivas et al., 2002) . This fact suggested that other nucleotides such as diadenosine polyphosphates could be also released in a similar way. Carracedo and co-workers found that shear stress stimuli induced Ap 4 A and Ap 5 A release from human corneal epithelial cells both In vitro and In Vivo . The results obtained In vitro were consistent with Srinivas findings (Srinivas et al., 2002) . Since in the studies performed by Carracedo, shear stress did not increase the amount of lactate dehydrogenase in human, the presence of Ap 4 A and Ap 5 A was not a consequence of cell rupture, although the exact mechanism of release remains to be determined. Mechanical perturbations such as cell stretching (Patel et al., 2005) , hydrostatic pressure (Cockayne et al., 2000; Ferguson et al., 1997; Knight and Burnstock, 2001 ) and compressive stress (Sauer et al., 2000) seem to be the candidates to trigger the release of these dinucleotides. The motion of the upper eyelid during the blinking process seems to be responsible for exerting shear stress on the epithelial cells and therefore increasing the levels of both diadenosine polyphosphates, concomitantly with the increase in the blinking frequency Rat, mouse and human Epithelial migration and stroma reorganization (Dutot et al., 2008; Groschel-Stewart et al., 1999; Mayo et al., 2008 ) P2Y 1 , P2Y 4 Rabbit, rat and human Undetermined (Klepeis et al., 2004; Pintor et al., 2004b) P2Y 2 Monkey, rabbit, rat and human Re-epithelization, corneal proliferation and corneal permeability increasing (Cowlen et al., 2003; Crooke et al., 2009; Klepeis et al., 2004; Loma et al., 2015b; Mediero et al., 2008; Pintor et al., 2004b) P2Y 6 Rabbit, rat and human Re-epithelization delay and corneal proliferation increasing (Klepeis et al., 2004; Mediero et al., 2006; Pintor et al., 2004b) P2Y 11 Rabbit and human Undetermined (Klepeis et al., 2004 ) Conjuctival Epithelium P2X7 Human Membrane permeabilization associated with iatrogenic pathology (Dutot et al., 2008) P2Y 2 Monkey, dog, rabbit and human Tear fluid and mucin secretion stimulation (Cowlen et al., 2003; Jumblatt and Jumblatt, 1998; Li et al., 2001; Murakami et al., 2000; Terakado et al., 2014) Rat and monkey Undetermined (Cowlen et al., 2003; Tanioka et al., 2014) described above were collected in subjects from 18 to 38 years old (Pintor et al., 2002a) . The age is considered one the most relevant factors to suffer dry eye, this may be due to the reduction in the lacrimal production or due to the increase in the evaporation rate associated with aging (Mathers et al., 1996) . There are many studies corroborating this assumption, in spite of the percentage of prevalence which is very variable, changing from 5% to 35% at 50 years old, or 20%e40% at 80 years of age (Moss et al., 2000; Schein et al., 1997 ) (Chia et al., 2003; Lee et al., 2002; Lin et al., 2003; Schaumberg et al., 2003 Schaumberg et al., , 2009 Viso et al., 2009 ), although there is consensus that the prevalence increases significantly after 50 years of age. The other main factor to develop dry eye is gender, it being more common in women than men. The Beaver Dam study showed a prevalence of dry eye of 18% in women and only 11% in men, and some other studies described even higher differences between women and men (Paulsen et al., 2014) . The principal reason for these differences would be the hormonal factor (Guillon and Maissa, 2010) . Due to the effect of some dinucleotides on the tear secretion (see section 2.1.7.), our research group considered it interesting to evaluate the variations in diadenosine polyphosphates concentrations as a function of aging and gender. Ninety-three healthy subjects were recruited to participate in the study. The age range was from 7 to 90 years old. Of the total 93 subjects, 47 were men and 46 were women, all of them without any ocular surface pathology. The levels of Ap 4 A and Ap 5 A were analyzed with and without anesthetic, discarding Ap 3 A due to the low concentration found in a previously study (Pintor et al., 2002a) .
The obtained results showed that Ap 4 A concentration remained stable until 50 years old, increasing its concentration significantly from this age (p value < 0.01; one way ANOVA). However, no significant changes were found for Ap 5 A concentration throughout the age range (p ¼ 0.245, one way ANOVA, Fig. 4 ). When comparing Ap 4 A concentrations in function of gender, it was found that there was more diadenosine tetraphosphate in men tears than in women, but without a statistically significant difference (p value ¼ 0.078; tStudent test for independent samples). For Ap 5 A, the concentrations were similar in both groups of subjects (p value ¼ 0.761; tStudent test for independent samples, Fig. 5 ). As we will see in the following section, a correlation between the age (dry eye disease main factor), and Ap 4 A concentration appears to exist.
Presence in ocular surface pathology
The relationship between dry eye and dinucleotides has been proposed in two different ways: as molecular biomarker and as treatment for the pathology. Peral and co-workers were the first to evaluate the levels of diadenosine polyphosphates in tear secretions in two groups of dry eye symptomatic subjects, one with low tear secretion volume and another with normal tear volume . They found that Ap 4 A and Ap 5 A were increased 5-and 1.5-fold in dry eye subjects with normal tear volume, respectively, compared with healthy subjects in the same age range. The dinucleotide concentrations were 0.590 ± 0.330 mM for Ap 4 A and 0.058 ± 0.017 mM for Ap 5 A. For symptomatic patients with low tear production the increase was higher, being 100-and 345-fold more than the value obtained in the healthy group. The concentrations were 10.68 ± 1.87 mM for Ap 4 A and 12.45 ± 0.20 mM for Ap 5 A. From these results, the authors proposed these molecules as an objective biomarker for scoring the severity of dry eye. In 2010, a research paper was published about the diadenosine polyphosphate concentrations in one of the most severe types of dry eye, Sj€ ogren Syndrome (Carracedo et al., 2010) . This autoimmune disorder is produced when the immune system attacks its own exocrine glands by mistake, especially the salivary and lacrimal ones (Srinivasan and Slomovic, 2007) . The mean concentrations of Ap 4 A, and Ap 5 A in the Sj€ ogren syndrome group were 2.54 ± 1.02 mM and 26.13 ± 6.95 mM, respectively. When this group was divided into two subgroups, normal and low tear secretion, the concentrations in normal tear secretion group were 0.47 ± 0.20 mM for Ap 4 A and 8.30 ± 3.27 mM for Ap 5 A. The subgroup with low tear secretion showed dinucleotide concentrations of 4.09 ± 1.36 mM and 39.51 ± 8.45 mM for Ap 4 A and Ap 5 A, respectively. It has been reported that the upregulated presence of P2Y 2 in the salivary glands increases the epidermal growth factor receptor (EGFR) e dependent expression of vascular cell adhesion molecule (VCAM)-1 and provokes the lymphocyte infiltration associated with the inflammation (Baker et al., 2008; Schrader et al., 2005) . Meanwhile this receptor has not yet been located in the lacrimal gland, a similar effect could occur in Sj€ ogren Syndrome (Tanioka et al., 2014) . Therefore, the high concentrations of diadenosine polyphosphates in Sj€ ogren syndrome patients would not be able to stimulate more lacrimation; they may even increase lymphocyte infiltration.
Another condition related with dinucleoside concentration in tears is congenital Aniridia. This inherited pathology is a rare disorder due to the mutation of the PAX6 gene (Glaser et al., 1992 (Glaser et al., , 1994 , located in the short arm of the chromosome 11. The main feature of aniridia is the partial or total absence of the iris, but the ocular surface is also affected with limbal stem cell deficiency, tear film disorders, corneal keratopathy and dry eye (Mayer et al., 2003) . It seems that dinucleoside play an important role in the progression of the pathology, since the Ap 4 A and Ap 5 A concentration increases with age, being higher in patients over 40 years of age than in younger aniridia patients. It has been demonstrated that P2 purinergic receptors are associated with differentiation, proliferation and neurogenesis in neonatal and adult mouse olfactory epithelium (Jia and Hegg, 2012) . In the corneal epithelium the cell proliferation process is initiated by P2Y 2 receptor activation via the ERK1/2 pathway (Muscella et al., 2004) . Therefore, the increased levels of diadenosine polyphosphates have been proposed as a compensatory mechanism to stimulate the proliferation and differentiation of limbal stem cells that are deficient in aniridia disorder.
Dinucleotide presence in the tear film has been related to dry eye disorders, cell migration and proliferation disorders. Inflammation is another biological process where the purinergic receptors and dinucleotides are involved (Guzman-Aranguez et al., 2014) . The main ocular surface condition, with dry eye, which is probably associated with inflammation is keratoconus. It is a corneal disorder characterized by progressive corneal stromal thinning, a coneshaped protrusion of the corneal surface (ectasia) (Davidson et al., 2014; Romero-Jimenez et al., 2010) , that creates alterations of the corneal tissue surface that result in visual distortion and reduced tear film quality. Tissue degradation by keratoconus involves the expression of inflammatory mediators, and therefore patients exhibit higher levels of pro-inflammatory cytokines, cell adhesion molecules, and matrix metalloproteinases (MMPs) compared with normal individuals (Galvis et al., 2015; Lema et al., 2008; McMonnies, 2015) . The concentration of Ap 4 A is higher in keratoconus patients than in healthy subjects (Carracedo et al., 2015b (Carracedo et al., , 2016 . The reasons for this increasing are related with mechanical stimulation of the corneal epithelial cell, due to eye rubbing or also gas permeable (GP) contact lenses wearing. In both cases this could be the trigger to induce the release of the diadenosine tetraphosphate.
All studies performed on the relationship of Ap 4 A and dry eye disorders showed the increment of the concentration of this molecule in the tear film of dry eye patients, so this diadenosine polyphosphate has been proposed as a diagnostic tool for this condition. Fig. 6 summarizes the levels of Ap 4 A concentration in different ocular conditions compared with normal values.
Presence in contact lens wearers
As commented above, Carracedo and co-workers demonstrated that forced blinking in healthy subjects provokes an increment of Ap 4 A and Ap 5 A concentration in tears, corroborating In vivo that these dinucleotides are released by shear stress from the corneal epithelium . It is reasonable to think that mechanical stimulation by contact lens wearing may also induce dinucleotide release, especially if the lens is not well fitted.
There are some different designs and materials for contact lenses. Both parameters are important to provoke more or less shear stress over the ocular surface. Broadly speaking, contact lenses could be manufactured with soft and rigid materials. Actually, the most common soft material is based on silicone and fluoride molecules to enhance the oxygen transmissibility, and the rigid materials are gas permeable, seeking the same oxygen permeability than soft material (Jones et al., 2013; Nichols et al., 2013) . The design of contact lenses is also an important factor to take into account. Soft contact lenses have large diameters, beyond the limbus with a slightly movement during blinking (MaldonadoCodina and Efron, 2004; Wolffsohn et al., 2013) . Nevertheless, rigid gas permeable lenses have a small diameter with more edge lift and movement than soft contact lenses, provoking more discomfort during the wearing (Brennan et al., 1987; Carracedo et al., 2015a; Cornish and Sulaiman, 1996; Elbendary and Abou Samra, 2013; Fink et al., 1992) . Both contact lenses are bearing over the cornea Currently, there is a rigid gas permeable special design, called mini scleral lens and mainly indicated for keratoconus and severe dry eye which does not bear over the cornea, keeping a post lens tear meniscus between the cornea and the lens. As with soft contact lenses, its diameter is large, from 15.00 mm to 18.00 mm and therefore saving the cornea and the limbus (van der Worp et al., 2014) .
The effect of contact lens wearing on tear dinucleotide concentration has been studied in different material and designs. Guzman et al. reported the effect of soft contact lenses poorly fitted in the diadenosine polyphosphates concentration (GuzmanAranguez et al., 2007) . Twenty-three healthy subjects were recruited who wore soft contact lenses for 8 h showed Ap 4 A and Ap 5 A tear levels significantly increased due to the presence of the contact lens, being the increasing 20 fold greater for Ap 4 A than for Ap 5 A. They suggested that measurement of tear dinucleotides might be used as an index of satisfactory contact lens fitting (Guzman-Aranguez et al., 2015) .
Moreover, the relationship between dinucleotides in tears and rigid gas permeable lenses was studied for two different designs (Carracedo et al., 2012) . Alignment-fit aspheric rigid gas permeable lenses worn on a daily basis and reverse geometry lenses worn overnight were fitted in the mentioned study. Both contact lenses have the same material but not the same indication and wearing basis. The lenses which are worn during the day provoke more shear stress on the ocular surface due to the blinking mechanism, but lenses for overnight wearing do not have movement due to lack of blinking during the sleep period. This report found that patients with Ap 4 A increased its concentration in tears with both lenses designs in the first day after fitting, increasing 4-and 2-fold compared with the baseline visit, respectively. After one month, Ap 4 A continued increasing significantly with alignment-fit lenses but with lens overnight wear, Ap 4 A concentrations returned to baseline levels after 1 week. However, Ap 5 A concentrations remained stable during the study in both groups. This result shows again the effect of the shear stress over the ocular surface stimulating dinucleotide secretion.
As described above, scleral lenses are special contact lenses indicated for severe dry eye and keratoconus patients which do not bear over the cornea and its movement in the eye is very limited. It was interesting to study its wearing over the Ap 4 A concentration in tears. A study recently published, shows the results in keratoconus patients before and after eight hours of wearing (Carracedo et al., 2016) . Ap 4 A concentrations decreased after scleral lens wear from 0.41 ± 0.71 mM to 0.21 ± 0.52 mM, being statistically significant. It was expected that dinucleotide concentration remained stable but surprisingly the concentration was lower. This fact could be due to Ap 4 A degradation to its metabolites since the tear is stagnant behind the contact lens during eight hours. Fig. 7 summarizes the Ap 4 A concentration for all contact lenses reported in the literature.
Presence after ocular surface surgery
Another situation where the dinucleotide concentration in the tear film is interesting to be evaluated is after ocular surface surgery. The most common reason to undergo surgery in the ocular surface is the refractive correction. There are some types of procedures to do that but the most habitual are Laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). Both techniques are safe and effective methods producing similar refractive outcomes (Nejima et al., 2005; Toda, 2008) . LASIK, the lamellar flat cut induces sensory deprivation by severing the damage of stromal nerves. This nerve ablation provokes some ocular surface complications as dry eye sensation. However, PRK causes damage to the corneal sensory nerves by a debridement of corneal epithelium and stromal ablation (Perez-Santonja et al., 1999) . Presumably, if dinucleotides were released from nerve endings, patients who have had LASIK or PRK would show changes in tear levels of diadenosine polyphosphates.
Carracedo and co-workers found that the concentration of Ap 4 A rises in tears 5 and 3.5 fold compared with the pre-surgery dinucleotide values in both LASIK and PRK surgery in the next day after surgery, probably as consequence of corneal damage during the procedure (Carracedo et al., 2014) . After two weeks of both surgeries, the concentration decreases close to basal values although in LASIK it remains statistically higher. At the end of the study, 3 months later, the concentration was very similar to the pre- 4 A concentration (n ¼ 6, *** p < 0.001, t-Student test for related samples), while there is a trend rising Ap 5 A levels but the difference isn't significant. B) Picture illustrates an example of scleral lens and the significant decrease in Ap 4 A concentration induced after wearing (8 hours) in patients with keratoconus (n ¼ 26, *p < 0.05, t-Student test for related samples). C) Graph demonstrates the significant trend to increase Ap 4 A concentration after rigid gas permeable contact lenses in a daily wear (RGP CL), while there are no differences in Ap 5 A concentration except a decrease one week after fitting (n ¼ 22, **p < 0.01, ***p < 0.001, t-Student test for related samples). D) Graph shows a significant increase in Ap 4 A concentration after 1 day of Corneal Refractive therapy fitting (CRT: reverse geometry gas permeable contact lenses in overnight wear) which then returns to normal values. There are no differences in Ap 5 A concentration after CRT wearing except a significant decrease one month after fitting (n ¼ 22, **p < 0.01,***p < 0.001, t-Student test for related samples). Values represent means ± SEM. operative visit for both techniques. Guzman et al. have found that Ap 4 A trend to be higher than baseline, but not statistically significant, one week after LASIK surgery (Guzman-Aranguez et al., 2007) . The results from both studies matched, although it is important to notice that the lack of statistical significance in the study by Guzman et al., is probably due to the small size of the sample. For Ap 5 A, the concentration remained stable in both studies during all the period evaluated.
In a non-published study performed by our research group, dinucleotide concentration in tears was also measured in patients after Intraocular collamer Lens (ICL) surgery. This refractive surgery technique consists of introducing an intraocular contact lens in the anterior chamber through a small incision in the corneal periphery, close to the limbus (Kamiya et al., 2010; Uusitalo et al., 2002) . With this procedure the corneal neural network is preserved (Alfonso et al., 2013; Ali et al., 2014) . Our preliminary results show that both Ap 4 A and Ap 5 A do not change their concentrations in the tear film throughout the study. This fact suggests that diadenosine polyphosphates present in tears are not released by the nerve terminals present at the ocular surface, but it rather confirms that the dinucleotides delivered from ocular surface epithelium is induced by shear stress.
There are some studies describing how Ap 4 A has the ability to stimulate epithelial cell migration. In contrast, Ap 5 A has the opposite effect, inhibiting the cell migration (Crooke et al., 2009; Mediero et al., 2009 Mediero et al., , 2008 Mediero et al., , 2006 . So, the high concentration of Ap 4 A on the day after LASIK and PRK surgery could be used to accelerate the wound healing process.
Effect on tear secretion
Tear secretion is a physiological process because the tear forms the interface between the air and the ocular tissues. To lubricate and to provide nutrients to the ocular surface tissues and to protect against infections are the more critical features of the tear film. For a correct tear volume and stability, it is very important to maintain a compensated tear composition. A failure in the tear secretion may provoke several negative effects in the ocular surface such as discomfort, dryness, irritation or corneal and conjunctival staining (Herrero-Vanrell and Peral, 2007) . Dinucleotides participate in the secretion process of some compounds of tear film like aqueous component, mucins and proteins.
The presence of diadenosine polyphosphates in tears of both animals and humans suggests that they may modify the physiology of the ocular surface. Diadenosine tetraphosphate have demonstrated their capability to increase the tear volume in the ocular surface (Pintor et al., 2002b) . In the case of Ap 4 A the increment is up 60% compared to baseline values in experiments performed with New Zealand white rabbits. Ap 5 A and Ap 6 A also significantly increased tear production by about 20% but, Ap 2 A and Ap 3 A are completely ineffective. However, it has not been fully clarified if the effect of these dinucleotides is to induce tear production at the lacrymal gland or in other secretory structures. The studies performed with animal models, suppressing the effect with RB-2, suggest that diadenosine polyphosphates act as agonist of P2Y 2 receptors for increasing the tear production (Murakami et al., 2000; Pintor et al., 2002b) . Curiously, the combination of melatonin with Ap 4 A enhances the effect of the diadenosine over the tear secretion in an animal model, but melatonin does not have any effect when it is applied alone. The authors blocked the effect of this combination applying luzindole, an antagonist of melatonin receptors (Hoyle et al., 2006) . It has not been described how melatonin and its receptors increase the effect of Ap 4 A but a possible mechanism is the heterodimerization of both dinucleotides and melatonin receptors. Both families receptor are coupled to G-protein and it has been suggested that actually these receptors could be organized as heterodimers between different G-protein coupled families (Levoye et al., 2006) .
Other dinucleotides which demonstrate their secretagogue propierties is Gp 4 G and Up 4 U. Recently in our lab, it has been proved that diguanine tetraphosphate (Gp 4 G) increases tear secretion in around 40% above normal tear values in New Zealand White rabbits. As diadenosine tetraphosphate, it is expected that this action is mediated by P2Y 2 (Guzman-Aranguez et al., 2015) . But the dinucleotide probably most studied is Up 4 U, also called INS-365. First studies in animal models showed its properties to enhance tear secretion (Fujihara et al., 2001; Murakami et al., 2000 Murakami et al., , 2002 Yerxa et al., 2002a) . These results, as a secretagogue, were the prelude of Diquafosol, an ophthalmic formulation based on this compound, developed as a new treatment for dry eye and was recently approved for marketing in Japan and South Korea (Jacobson et al., 2012; Nakamura et al., 2012) .
Diquafosol has shown its capability to increase the aqueous and mucin portion of tears Nakamura et al., 2012; Takamura et al., 2012; Tauber et al., 2004) . In recent years, diquafosol has been used for treating different conditions related with dry eye (Table 2 ). This dinucleotide improves the tear secretion and symptomatology in Sj€ ogren syndrome (Bremond-Gignac et al., 2014; Yokoi et al., 2015) , aqueous deficient dry eye (Koh et al., 2013a (Koh et al., , 2014 , contact lens wearers (Nagahara et al., 2015) , Meibomian gland dysfunction (Arita et al., 2013; Yamaguchi et al., 2015) , dry eye related with cataract surgery (Miyake et al., 2014; Park et al., 2015) , even in normal eyes (Gendaszewska-Darmach and Kucharska, 2011; Nam et al., 2015; Yokoi et al., 2014) . Regarding the safe use of diquafosol, the majority of adverse reactions, found in different clinical trials, were of mild severity, and no serious treatment-related adverse events were reported. Adverse reactions were observed in 6.3% of patients, and the major adverse reactions were eye irritation, and eye pain. It seems that good tolerance shown by diquafosol ophthalmic solution 3% remained in the longer term (Takamura et al., 2012; Wu et al., 2015; Yamaguchi et al., 2014) .
Effect on tear components
The tear film is a complex solution composed of proteins, lipids, carbohydrates and electrolytes. Two main features of the tear film are to protect the ocular surface against potential pathogens and to lubricate and wet the corneal and conjunctival epithelia. So, the tear film has some antimicrobial components that are able to kill the pathogens or at least to inhibit their replication. The main proteins in the tear film performing this task are lysozyme, lactoferrin, immunoglobulin A (IgA) and tear lipocaline (Farris, 1986; Kuizenga et al., 1996; Cabrera et al., 1997) .
Lysozime presents a bactericide action against gram-positive bacteria, such as Micrococus lisodeikticus, catalyzing the hydrolysis of 1,4-b junctions between N-acetylmuramic acid and N-acetyl-Dglucosamine in the main chain of peptidoglycans of cell membrane (Burman et al., 1991; Qasba and Kumar, 1997) . This protein is secreted by the main and accessories lacrymal glands, representing 25% of total proteins in the tear film. Peral and co-workers investigated the effect of dinucleotide instillation on the lysozyme concentration in the tear film . Their hypothesis was based on several studies that have shown a decrease in the concentration of lysozyme in patients with dry eye (Caffery et al., 2008; Mackie and Seal, 1984; van Bijsterveld, 1969 ). The topical application of 100 mM of Ap 4 A and Up 4 U (aka diquafosol) increased the lysozyme levels after one hour of instillation, remaining higher than baseline during four hours. The maximum value was reached at two hours for both dinucleotides, being the increase in lysozyme concentration of 93% for Ap 4 A, 119% for Up 4 U.
Another interesting molecule with bacteriostatic properties is (Kamiya et al., 2012) lactoferrin. Particularly, lactoferrin is an iron-binding protein, thus reducing the availability of iron necessary for microbial growth and survival. Additionally, the anti-inflammatory actions of this protein have also been proposed (Arnold et al., 1977; Conneely, 2001 ). The dinucleotide Ap 4 A was able to increase lactoferrin concentration from 68 ± 4 mg/ml to 83.17 ± 9.89 mg/ml at 1 h of instillation. This effect was slightly increased at 2 h and continued for 2 h more until it returned to the baseline values (Loma et al., 2016) . The increasing of lysozyme and lactoferrin after dinucleotides instillation is mediated by purinergic receptors activation. The presence of different P2X and P2Y receptors on the ocular surface were noted. Ap 4 A and Up 4 U mainly stimulate P2Y 2 , but Ap 4 A can also act on P2X2, P2X4, P2Y 1 and P2Y 2 receptors. Previous studies showed that the tear secretion is stimulated with Ap 4 A by P2Y 2 receptors Pintor et al., 2002a) . The antagonists used in the study of lysozyme and the lack of effect of some nucleotides such as UDP and ADP (preferential agonists of P2Y 6 and P2Y 1 but also agonists of P2Y 12 , P2Y 13 and P2Y 14 ) (Ralevic and Burnstock, 1998) may suggest that P2Y 2 is responsible for this, since only P2Y 2 actions have been demonstrated on lysozyme production .
For lactoferrin, Ap 4 A action was also mediated by purinergic receptors activation. Although the lacrymal gland is the major source of tear lactoferrin, it has been demonstrated that ocular surface epithelial cells also produce detectable amounts of lactoferrin (Flanagan and Willcox, 2009; Santagati et al., 2005 ) with higher expression in conjunctival than corneal epithelial tissue suggesting that activation of P2 receptors identified in these localizations could also be involved in lactoferrin secretion. The authors used some selective antagonist for P2Y 1 , P2X4 and P2Y 2 , and they found that only AR-C118925XX (selective P2Y 2 purinergic receptor antagonist) blocked the effect of Ap 4 A. Moreover, PPADS (antagonist of mainly P2X but also P2Y 1 receptors) was also tested to evaluate the activation of other P2X receptors, and indeed it was able to partially reverse Ap 4 A action. Altogether, it seems that the lactoferrin production is mainly triggered by P2Y 2 purinergic receptor, but the participation of a P2X and a P2Y 1 receptor cannot be discarded.
Since both proteins, lysozyme and lactoferrin are the first defense mechanism against microbial infection, dinucleotides might provide additional protection by increasing the natural agents in tears of healthy subjects. Moreover, the increasing of these proteins could help to stabilize the tear film, avoiding an excessive tear evaporation rate and ocular surface desiccation. In particular, the lactoferrin diminishes the superficial tension of the tear film (Millar et al., 2006; Tragoulias et al., 2005) .
Other important molecules for tear film stability and homeostasis are the mucins. Mucins are high molecular weight glycoproteins that are produced by corneal and conjunctival epithelial cells present in the ocular surface (Murube, 2012) . There are three families of ocular mucins based on their amino acid sequence: transmembrane (MUC1, MUC3A, MUC3B, MUC4, MUC12, MUC13, MUC15, MUC16, MUC17, MUC20, and MUC21), secreted gelforming (MUC2, MUC5AC, MUC5B, MUC6, and MUC19) and secreted soluble mucins (MUC7 and MUC9). Other mucins such as MUC8 and MUC11 have not been classified yet (Corrales et al., 2011; Murube, 2012) .
The main actions of mucins are to clean, lubricate and protect the ocular surface from adverse environmental conditions (Mantelli and Argueso, 2008; Murube, 2012) .
Based on the response elicited by UTP and ATP on isolated human and rabbit conjunctivas, Jumblatt and Jumblatt suggested the involvement of P2Y 2 purinergic receptors in mucin secretion (Jumblatt and Jumblatt, 1998) . Moreover, Murakami et al. showed that the UTP/ATP-mediated mucin secretagogue effect was reversed in rabbits pre-treated with suramin (Murakami et al., 2003) . The antagonist suramin blocks all P2Y receptors with the exception of the P2Y 4 receptor (von Kugelgen, 2006) . Thus, and taking into account that P2Y 2 receptor is expressed in the Fig. 8 . Visualization of the mucin secretion by confocal microscopy. Impression cytology samples were preserved in 96% ethanol and after being processed by the periodic acid Shiff, were dehydrated in different levels of ethanol, put on xylol and finally mounted in coverslips for further observations by means of the laser confocal microscope. A) Frontal view of goblet cells and their mucin secretion (red) and conjunctival epithelial cells (green). B) Perpendicular perspective of mucin cloud secreted by goblet cell in basal condition. C) Perpendicular view of mucin cloud after INS-365 treatment. Fig. 9 . Variations in mucin cloud height after dinucleotides and nucleotides (agonists P2Y 2 ) treatment. Graph shows the significant increase on mucin cloud height in rabbits after the treatment with all nucleotides (n ¼ 3, Tukey-Kramer test; *p < 0.05, **p < 0.01, ***p < 0.001), which is maximal after INS-365 application being about 3-fold higher than control. Values represent means ± SD. conjunctival epithelium of rabbits and monkeys (Cowlen et al., 2003) , it has been considered that the P2Y 2 receptor governs the conjunctival mucin secretion. Both Ap 4 A and Up 4 U are agonists of P2Y 2 receptor so they should promote the mucin secretion from conjunctival Goblet cells.
The first study on dinucleotides and mucin secretion in tears was published in 2001 (Fujihara et al., 2001) . They found that INS-365, aka Up 4 U and also termed diquafosol (see section 2.1.7), has the ability to evoke mucin secretion on In vivo conjunctivas of a rat dry eye model. In 2004 they corroborated their results in the New Zealand white rabbit model (Pintor et al., 2004a) . They concluded that INS365 restored moisture and hydration of the ocular surface of rats by its effects on tear and mucin secretion. Other authors have found the same effect of INS-365 in different animal models, increasing Goblet cell Density and mucin production Kojima et al., 2014; Terakado et al., 2014) .
Our research group performed a study to evaluate the possible involvement of other P2Y receptors, not only P2Y 2 , such as P2Y 4 and P2Y 6 in rabbit conjunctival mucin secretion, testing the mucin secretagogue effect of the dinucleotide Ap 4 A and INS-365. The technique used for ocular mucin visualization was confocal laser scanning microscopy (Fig. 8 ). This technique, following the protocol stablished by Peral and Pintor, allows us to measure mucin cloud height (MCH) over the goblet cell. In this sense, all the dinucleotides tested evoked a significant increase of the MCH parameter in comparison with control animals. The rank order of effect on mucin secretion was INS-365 (MCH ¼ 9.50 ± 1.72 mm) greater than UTP (MCH ¼ 6.50 ± 0.49 mm) and greater than Ap 4 A (MCH ¼ 3.75 ± 0.79 mm), Fig. 9 .
It was also observed that the secretory effect of INS-365 and UTP was more robust than that obtained by Ap 4 A. This fact suggests the involvement not only of P2Y 2 receptors but also of other uracil nucleotide-sensitive receptors. To determine the possible purinoceptors involved in mucin secretion RB-2, suramin and PPADS antagonists were applied on rabbit conjunctiva in the presence or absence of INS-365. RB-2 was the most effective purinoceptor antagonist, reducing INS365-evoked MCH by 3.5-fold (MCH RB-2 þ INS365 ¼ 3.18 ± 0.83 mm versus MCH INS-365 ¼ 11.20 ± 0.37 mm). Suramin and PPADS also reduced the MCH value in comparison with rabbits treated with INS365 alone, but they were less effective. Taking into account that RB-2 is a very weak antagonist of P2Y 2 receptors, a modest antagonist of P2Y 4 receptors and a potent antagonist of P2Y 6 receptors (Abbracchio and Ceruti, 2006; von Kugelgen, 2006) , it seems that P2Y 6, and to a lesser extent P2Y 4 receptors, play an important role in rabbit conjunctival mucin secretion.
There is only one study regarding INS-365 (Diquafosol) and mucin production in human conjunctiva epithelium. Sigheyasu et al. related a significant increase of sialic acid concentration, a good marker for evaluating mucins in biological samples (Shigeyasu et al., 2015a (Shigeyasu et al., , 2015b , in tears after Diquafosol instillation in healthy human eyes. This finding corroborates the data described in animal model by other authors Kojima et al., 2014; Terakado et al., 2014) .
Contact lens delivery of dinucleoside polyphosphates
The most common system to treat ocular conditions is by applying eye drops (Kojima et al., 2008; McCann et al., 2012) . Sometimes, the use of punctal plugs are necessary to increase the resident time of the active molecule on the ocular surface (Karcioglu and Fleming, 2008) . Probably the major challenge to treating ocular pathologies, including surface disease such as dry eye, is to enhance the bioavailability, reduced by the complex structure of the ocular surface. In this context, contact lenses have been proposed as new vehicle for drug delivery. Contact lenses are separated from the cornea by a thin fluid layer called post-lens tear film. The clearance time of the post-lens tear film in soft contact lenses is about 30 min (McNamara et al., 1999) . Thus, ophthalmic drugs released from the contact lenses will have a residence time in front of the cornea for at least 30 min compared to 2 min for eye drops. This method is currently being investigated to deliver molecules as anti-inflammatory, antibiotics or lubricants molecules on the ocular surface. In the case of dinucleotides, contact lens delivery system has been used with Ap 4 A to improve the secretagogue function of this molecule.
For experiments, two materials of hydrophilic contact lenses (Omafilcon A and Ocufilcon A) and another two materials of hydrogel-silicone contact lenses (Comfilcon A and Balafilcon A) were used. All lenses were uploaded with 1 mM Ap 4 A solution.
In vitro experiments showed that dinucleotide delivery from contact lens was more prolonged with non-ionic material (Omaficon A and Comfilcon A) than ionic material Ocufilcon A and Balafilcon A). Moreover, the delivery rate was better in hydrogel-silicone lenses than hydrophilic lenses. In vivo experiments reported that Ap 4 A delivery from non-ionic hydrogel-silicone contact lens was able to induce tear secretion higher than baseline values during 360 min (Dominguez-Godinez et al., 2013) . It seems that the ionic charge of the contact lens materials could be the major factor in Ap 4 A delivery. In this sense, it is important to note that Ap 4 A is a dinucleotide presenting four phosphates that in neutral pH present four negative charges (Patane et al., 2011) . This could be the reason why those lenses with ionic charge, which is also negative, may repel Ap 4 A and the molecule delivery is faster.
Effect on corneal wound healing
The corneal epithelium are in permanent renovation, being complete every 7e10 days (Liu and Kao, 2015) . The proliferation and differentiation of limbal cells are responsible for the epithelium renovation. The new epithelial cells come to the mitotic activity of limbal basal cells which replace the old epithelial cells following a centripetal and superficial movement (Lemp and Mathers, 1989) . When the epithelium is damaged, the reepithelization process or wound healing begins, following three phases: latency phase, migration phase and cell mitosis (Suzuki et al., 2003) .
There is cell reorganization during the latency phase. The synthesis cytoskeletal proteins, such as actine, vinculin and taline, and ocular surface glycoproteins begins in this phase to act in the migration phase. Moreover, the wound area increases in this phase due to the action of some leucocytes from the tear film, eliminating necrotic cells (Panjwani et al., 1990; Suzuki et al., 2003) . The migration phase mainly depends on actin filaments activation and other proteins to promote the movement of the cells from the periphery to the wound centre (Kurpakus et al., 1999) . Finally, the cell division phase completes the wound healing process (Lehrer et al., 1998) .
It has been described that some molecules released from the corneal nerves stimulate the wound healing process after ocular surface injuries (Muller et al., 2003) . Among natural substances, nucleotides and dinucleotides present in tears have been shown to be very active to modify the rate of healing (Bowman and Green, 1981; Pintor et al., 2004a) . Experiments performed in our laboratory on an animal model, demonstrated that the levels of Ap 4 A and Ap 5 A are significantly reduced after the damage, recovering after 10 h. The same ratio of Ap 4 A/Ap 5 A concentration in tears remained stable. This means that diadenosine polyphosphates remain low during the latency phase and recover during the migration phase, suggesting their involvement in the migration process (Mediero et al., 2006) .
Nucleotides influence the corneal epithelial cells healing rate by either accelerating or decelerating the healing process. Pintor et al. found that the estimated healing time was for saline, Ap 3 A, Ap 4 A and Ap 5 A were 32.2 ± 2.0 h, 35 ± 2.6 h, 26.0 ± 0.6 h and 29.2 ± 2.2 h, respectively. It means that only diadenosine tetraphosphate provokes an increase in the wound healing rate (Pintor et al., 2004a) . Based on these results, Mediero et al. evaluated the role of diadenosine polyphosphate in the epithelial cell migration, performed in primary corneal epithelial cell culture (Mediero et al., 2006) . Ap 4 A accelerate 5 h the wound healing whereas Ap 3 A and Ap 5 A delayed it 6.5 h and 10 h respectively. The opposite effects may be justified by the activation of different P2Y receptors subtypes present in the ocular surface (Klepeis et al., 2004; Weinger et al., 2005) . Both Ap 3 A and Ap 5 A are agonist of P2Y 6 and Ap 4 A of P2Y 2 . So, it seems that P2Y 2 receptor stimulates the wound healing process and P2Y 6 inhibits it.
Due to there not being a selective agonist for P2Y 2 receptor, its implication in epithelial wound healing has been studied by silencing it with small interference RNA (siRNA) against the rabbit P2Y 2 receptor. The authors performed In vitro and In vivo migration analysis showed that the silencing process reduced the corneal cells migration when Ap 4 A was instilled, even showing less wound healing than control group (without Ap 4 A instillation). It seems to demonstrate the effect on wound healing of the natural Ap 4 A in tears, mediated by P2Y 2 (Crooke et al., 2009) . Moreover the involvement of the P2Y 2 receptor has been demonstrated by other authors (Boucher et al., 2010; Sanderson et al., 2014) . Mediero et al. demonstrated that the activation of the P2Y 2 receptor with Ap 4 A, accelerates corneal epithelial cell migration during wound healing with the activation of mitogen-activated protein kinase (MAPK) and cytoskeleton pathways, whereas activation of the Ap 3 A/P2Y 6 receptor signals only the MAPK pathway (Mediero et al., 2008) . Moreover, phospholipase C/Protein Kinase C (PLC/PKC) pathway in the activation of ERK1/2 and ROCK-I is involved (Mediero et al., 2011) .
Effect on epithelial permeability
Corneal permeability has also been studied under the dinucleotides application. Eye diseases are often treated by topically administered drugs. However, as commented in section 2.1.9, ocular drug delivery is strongly limited by the barriers of the eye resulting in poor drug bioavailability (Kompella et al., 2010) . The cornea is a chemical and mechanical barrier that stops the entry of any foreign body, included drugs, to the anterior chamber (Leong and Tong, 2015) . The corneal epithelium is the layer with a stronger barrier function (Gobbels et al., 1990; McNamara et al., 1997; Yokoi and Kinoshita, 1995) , meanwhile the stroma and endothelium give less resistance to transcorneal permeability (Huang et al., 1983 (Huang et al., , 1989 .
Fujihara et al. evaluated the corneal barrier function with a modified anterior fluorometer measuring fluorescein penetrance (Fujihara et al., 2001) . They found that INS-365 as low as 1% decreases the dye penetrance approximately by 50%. They suggested that this action was mediated by P2Y 2 but they did not test the implication of this metabotropic receptor.
The involvement and the effect on corneal permeability mediated by P2Y 2 receptors have been quite different when studied by other authors. By means of the transepithelial electrical resistance (TEER) it has been possible to demonstrate that the dinucleotide Ap 4 A is able to open the paracellular corneal epithelial barrier being the effect transitory and maximal 2 h after the application of the dinucleotide (Loma et al., 2015b) . This is an interesting function of Ap 4 A because its topical application could "open the door" to other compounds to treat internal ocular pathologies such as glaucoma or intraocular infections.
The possibility of facilitating the paracellular way for the delivery of compounds within the eye presents two main advantages: first, to increase the effect with less concentration of the drug and concomitantly and second less adverse events In this way, Ap 4 A administration showed that, when it was topically applied two hours before the application of a classical adrenergic compounds for glaucoma treatment, the concentrations of brimonidine and timolol in the aqueous humour increased from 64.3 ± 5.3 nM to 240.6 ± 8.6 nM and from 58.9 ± 9.2 nM to 183.7 ± 6.8 nM respectively, and this also produced a more robust reduction in IOP than when they are applied alone (Loma et al., 2015a) .
Diadenosine tetraphosphate effect is produced by the temporary disruption of the tight junctions present in the corneal epithelium (Loma et al., 2015b) . These tight-junctions form an epithelial junctional complex with the adherens junctions and desmosomes to avoid the entry of substances within the eye (Ban et al., 2003) . Tight junctions are multifunctional and dynamic protein complexes that connect adjacent cells by sealing the intercellular space between cells preventing the paracellular movement of solutes, ions and water. The main proteins forming a tight junction in the cornea are occludin (Langbein et al., 2002) , claudins (Ban et al., 2003) and zonula occludens-1 (ZO-1) (Ban et al., 2003; Sosnova-Netukova et al., 2007; Yoshida et al., 2009) . It was possible to measure the effect of Ap 4 A on tight junction proteins by western blot and the three mentioned proteins, claudin, occludin-7 and ZO-1, showed a clear reduction in its expression 2 h after the dinucleotide application, the fall of expression being 59.3% for ZO-1, 57.9% for occludin-7 and 58.8% for claudin (Loma et al., 2015b) .
The implication of P2Y 2 in Ap 4 A in the mentioned effect was also demonstrated. An elegant approach to demonstrate the importance of this receptor on the Ap 4 A effect on corneal barrier was performed by using P2Y 2 receptor siRNAs. Silencing the P2Y 2 receptor completely abolished the effect of drug delivery carried out by Ap 4 A. Moreover, the proteins that form the commented tightjuntions remained unaltered in the presence of the dinucleotide. As happens in the Ap 4 A wound healing stimulation, the effect of Ap 4 A was mediated by P2Y 2 activation coupled with ERK1/2 pathway (Loma et al., 2015b) .
Dinucleoside polyphosphates in the anterior pole
Presence in the aqueous humour
Aqueous humour, the secretion that nourishes the avascular structures of the eye such as cornea and lens, contains dinucleoside polyphosphates at low micromolar concentration (Castany et al., 2011; Pintor et al., 2003) . Among the different dinucleotides, Pintor and colleagues have identified and quantified the presence of Ap 4 A (0.34 mM) and Ap 5 A (0.08 mM) in the aqueous humour of rabbits (Pintor et al., 2003) . These compounds are also present in the aqueous humour of human, with levels of 0.020 mM (for Ap 4 A) and 0.021 mM (for Ap 5 A) (Castany et al., 2011) . Moreover, in glaucoma patients, Ap 4 A concentration is 15 times higher than in normal individuals (Castany et al., 2011) .
The origin of the dinucleotides in aqueous humour has only recently been elucidated as a mechanism dependent of the ciliary body epithelium although some clues about their extracellular origin were suggested some years ago (Pintor et al., 2003) . In the case of nucleotides such as ATP, Mitchell and colleagues have demonstrated its direct release from ciliary epithelial cells in culture (Mitchell et al., 1998) .
A key point in the release of nucleotides to the aqueous humour is the TRPV4 channel described as ciliary body epithelial cells which indeed mediates in the release of different substances to the aqueous humour (Alkozi and Pintor, 2015) . In this sense, either by producing osmotic changes, which is one of the main features of this TRPV channel, or by using selective agonists such as GSK1016790a, it has been seen that the amount of diadenosine tetraphosphate almost triplicates its extracellular concentration . The mechanism of such release is mostly carried out by pannexins (pannexin 1) in a percentage of 40%, the same percentage with connexins and finally 20% by exocytosis . The molecular mechanisms that connect TRPV4 with pannexin and connexons are still under investigation, since the exocytosis may be explained by the typical Ca 2þ entry produced when the TRPV4 channel is activated. In general, the activation of a TRPV4 channel is relevant since changes in the hydrostatic and osmotic pressure, typical in many types of glaucoma, may respond to such variations in the aqueous humour dinucleotide concentration. Nevertheless, it is important to note that another important structure which may contribute to the release of nucleotides and dinucleotides to the aqueous humour, is the lens. Several studies have reported that in this structure the release of nucleotides such as ATP is also performed by means of a TRPV4 and via mechanisms that involve the participation of hemichannels (Shahidullah et al., 2012a (Shahidullah et al., , 2012b .
The presence of the compounds Ap 3 A (Szwergold and Lal, 2005 ) and Ap 4 A as well as the release of the latter, has been demonstrated in mice. Interestingly, the release of the mentioned substance varies depending on the mice strain used. The strains FVB and C57, release equivalent amounts of Ap 4 A providing concentrations of about 1.3 nM, while in the glaucomatous mice, DBA/2J, the concentration of Ap 4 A is 5.9 nM. Indeed, the changes in the aqueous humour, making it more hypoosmotic, despite affecting the three mice strains, was particularly remarkable in the DBA/2J glaucomatous animal when the levels increased to 61 nM. It seems, therefore, that the lens presents a very relevant role in the release of nucleotides to the aqueous humour and particularly in models of glaucoma as indicated. The ability of the lens to release nucleotides is probably due to its enormous concentrations of nucleotides, being the tissue with higher nucleotide levels in the whole body (Pintor, 2011) . It is interesting to notice that nucleotides, apart from developing the tasks of keeping the pumps and transporters, operative, nucleotides and dinucleotides develop a physical action avoiding the entry of some UV wavelengths to the retina by absorbing this damaging light (Pintor, 2011) .
The concentration, and thereby function, of Ap 4 A and Ap 5 A in the aqueous humour can also be controlled by ecto-nucleotidases. Corneal endothelial cells express NTPDase1 isoform as well as eN enzymes (Gomes et al., 2005) . Additionally, non-pigmented ciliary epithelial cells and ciliary stromal cells (endothelial and interstitial cells) express ENPP1, NTPD1 and eN/5NTE (Braun, 2010; Farahbakhsh, 2003) . On the other hand, trabecular meshwork cells express ENPP1-3, NTPD2 as well as NTPD8 and 5NTE . Since all these structures bathed by aqueous humour also present purinergic receptors, dinucleotides and their metabolites (i.e. ATP, ADP and adenosine) can regulate their physiological functions including corneal endothelial fluid transport, aqueous fluid production and drainage .
2.2.2. Effect on intraocular pressure 2.2.2.1. General effects. The intraocular pressure (IOP), which maintains the spherical shape of the eye, depends on the balance between the aqueous humour production and its drainage (Goel et al., 2010) . Aqueous humour is secreted by the ciliary processes of the ciliary body and is drained, mainly, through the trabecular meshwork into the canal of Schlemm (Goel et al., 2010) . Since both structures express nucleotide receptors Guzman-Aranguez et al., 2013) , dinucleotides but also their metabolites could regulate aqueous humour secretion/drainage and thereby modify IOP. Some dinucleotides such as the diinosine polyphosphates can also regulate IOP. Guzman-Aranguez and colleagues have described the ability of diinosine pentaphosphate (Ip5I) to increase IOP in normotensive rabbits . Conversely, diinosine triphosphate (Ip3I) and diinosine tetraphosphate (Ip4I) reduce IOP, the latter being the more potent hypotensive compound .
Indeed, the topical application of Ap 4 A in normotensive rabbits reduces IOP in a concentration dependent manner (Pintor et al., 2003) . Conversely, Ap 5 A (also present in aqueous humour), Ap 2 A and Ap 3 A increase the IOP of these animals (Pintor et al., 2003) . Although the topical application of diadenosine tetraphosphate on animal models is the reduction of IOP, studying the effects on the main ocular structures responsible for the aqueous humour dynamics, trabecular meshwork and ciliary body, the effects are the opposite. While in the trabecular meshwork Ap 4 A produces facilitation in the aqueous humour drainage, in the ciliary body this dinucleotide produces an increase in aqueous humour production.
2.2.2.2. Effect on the trabecular meshwork. Trabecular meshwork presents many P2Y receptors, mainly P2Y 1 , P2Y 2 , and P2Y 4 in bovine TM cells (Soto et al., 2005) and P2Y 11 in a cellular line of human trabecular meshwork (Crosson et al., 2004) . Diadenosine polyphosphates do not activate all these receptors in the same way. For instance, Ap 3 A and Ap 4 A can mainly activate P2Y 1 (Schachter et al., 1996) receptors, nevertheless it is important to note that Ap 4 A is also able to trigger P2Y 2 and P2Y 4 receptors (Lazarowski et al., 1995) . Indeed, the application of Ap 3 A and Ap 4 A increased outflow facility at low micromolar concentrations (Soto et al., 2005) , thereby contributing to the reduction in IOP previously detected in other animal models (Pintor, 2005) . The application of diadenosine polyphosphates in trabecular meshwork cells produces an increment in the intracellular Ca 2þ , but only in pharmacological studies, carried out by means of different mono and dinucleotide concentrations, as well as the use antagonists, permitted to identify which is responsible for the facilitation of outflow and Ca 2þ mobilization. In this sense, the P2Y 1 receptor agonist 2-MeS-ATP, together with Ap 3 A and Ap 4 A, suggests that this is the main P2Y receptor involved in the mentioned effects. Moreover, the blockade obtained by the P2Y 1 selective antagonist MRS-2179 on the drainage facilitation induced by Ap 4 A, and the sharp inhibition in the Ca 2þ increases, as previously commented, confirms that this is the main receptor responsible for the reduction of IOP at the trabecular meshwork (Pintor, 2005) .
2.2.2.3. Effects on the ciliary body. Some of the first actions where the effects of nucleotides and dinucleotides were detected in the ciliary body demonstrated the presence of P2X2 receptors in the ciliary muscle (Peral et al., 2009) . In this location and by means of the same ionotropic receptor, diadenosine tetraphosphate exerts the same actions other mononucleotides do. Interestingly, the action of Ap 4 A, seems to occur on the cholinergic terminals innervating the ciliary muscle. These terminals after the activation of the dinucleotide promote the release of acetylcholine that contracts the muscle via muscarinic receptors. This contraction pulls the scleral spur opening the irido-corneal angle and therefore facilitating the evacuation of the aqueous humour by the trabecular meshwork (Pintor, 2005) . In a clear difference to what was described previously, other actions of diadenosine polyphosphates, mainly Ap 4 A are mediated by P2Y 2 receptors present in the ciliary epithelium . The presence of this receptor and its activation produces an effect which is opposite to the one observed in the ciliary muscle and in the trabeculum. In the ciliary body the activation of this receptor with dinucleotides or mononucleotides (selective for the P2Y 2 receptor) produces a rise in IOP. This effect can be demonstrated when the P2Y 2 receptor is silenced by means of a siRNA, and in this case the lack of expression of this receptor produces a profound and long-lasting reduction in IOP .
The mechanism by which P2Y 2 receptor stimulated by Ap 4 A produces it effect seems to be a combination of several cellular mechanisms. It has been observed in non-pigmented ciliary epithelial cells that the activation of the P2Y 2 receptor increases the traffic of aquaporin 1 (AQ1) from intracellular stores to the plasma membrane (Martin-Gil and Pintor, 2010; Pintor, 2010) . This effect should be a consequence of the activation of the canonical pathway, which triggers PKC activation (Guzman-Aranguez and . The mobilization of AQ1 triggered by Ap 4 A, was able to mobilize AQP1 which was time dependent, the maximal expression in the cell membranes occurring 1 h after the application of the dinucleotide and returning to initial values in two hours' time (Martin-Gil and Pintor, 2010) . Unpublished results performed in our laboratory, demonstrated that apart from AQ1 trafficking there was a net flow of Cl À from ciliary epithelial cells, this ion being responsible for aqueous humour secretion. In other cellular models, achondroplastic chondrocytes, the effect of Ap 4 A was virtually identical. In this model, diadenosine tetraphosphate was also facilitating the efflux of chloride from these cells (Huete et al., 2011) . Therefore, it seems that there is a coordinated action triggered by the P2Y 2 receptor after the stimulation by Ap 4 A that produces a mobilization of AQ1 towards the membrane and an increase in the Cl À efflux, which altogether, would be responsible for the P2Y 2 mediated elevation of IOP (Fig. 10) .
Putative actions of dinucleotides in the lens
There are no studies in the literature investigating the role of dinucleotides in the lens. Therefore, a possibility is to suggest some of the possible effects, just by checking on the P2 receptors present in the lens that are suitable for stimulation by dinucleoside polyphosphates.
The lens epithelium can respond to the changes in the concentration of dinucleotides found in the aqueous humour as previously described. The identification of P2Y receptors (P2Y 1 and P2Y 2 ) by RT-PCR and in situ hybridization in the lens has been described (Cowlen et al., 2003; Hu et al., 2008; Merriman-Smith et al., 1998) . Because Ap 4 A is most representative of the dinucleotide in the aqueous humour, and its ability is known to stimulate both receptors, changes in Ap 4 A concentration could alter intracellular Ca 2þ concentration in cortical lens fibers. Moreover, calcium mobilization in the lens could modulate the activity of different Kþ channels (Rhodes et al., 2003) , which will determine the membrane potential of the lens, and subsequently the Cl À channels that contribute to lens volume regulation and transparency (Valverde et al., 1992) .
Neuroprotective role in the ciliary body
The neuroprotective effect of Ap 4 A is closely related to the fact that this dinucleotide is stored in synaptic vesicles together with different classical neurotransmitters (Miras-Portugal et al., 1998) . In this sense, apart from its roles inhibiting the epileptiform activity and synaptic potentials in the hippocampus (Klishin et al., 1994; Ross et al., 1999) and inhibition of glutamate release in the striatum (Oaknin et al., 2001) or the stimulation of locus coeruleus, Fig. 10 . Schematic representation of the involvement of the purinergic signaling in intraocular hypertension. Extracellular Ap 4 A activates the PLC/PKC signaling pathway through the stimulation of P2Y 2 purinergic receptors in non-pigmented ciliary epithelial cells. The activation of protein kinase C (PKC) causes trafficking of Aquoporin 1 (AQP1) to plasma membrane mediated by the phosphorylation of at least three subunits of AQP1. In the same way, the activation of phospholipase (PLC) leading to mobilization of calcium from intracellular stores together with the possible PKC-mediated phosphorylation could induce chloride channels opening. Both facts produce an increase in aqueous humor inflow and the subsequent rise on intraocular pressure (IOP). Moreover, the increase on IOP activates TRPV4 inducing a rise on calcium intracellular concentration, which at the same time produces the Ap 4 A release mainly through pannexin 1 and in lesser extent by vesicular exocytosis feeding back this process.
producing excitation (Frohlich et al., 1996) , this dinucleotide can present interesting properties protecting the nervous system from damage.
Studies performed at the CNS have demonstrated that Ap 4 A can give protection from the neurodegeneration induced by methylamphetamine either in In vitro or in In vivo experiments (Harvey et al., 2009 ). This protective effect also exists when cerebral ischemia exists or when sympathetic terminals are chemically damaged by means of 6-OH-dopamine .
Neurodegenerative diseases like Alzheimer's disease or Parkinson's, can affect, of course the CNS, but they also alter the autonomic nervous system causing dysautonomia, this being important in the eye since it can raise IOP augmenting the prevalence of glaucoma in patients suffering from these two pathologies which are significantly higher than in the normal population (Bayer et al., 2002) . Many patients with Parkinson's disease have a significant loss of their visual field which is typical of the development of glaucoma (Yenice et al., 2008) .
Since the presence of diadenosine tetraphosphate has been demonstrated in the aqueous humour both in humans and animal models (Castany et al., 2011; Pintor et al., 2003) , the possibility of this dinucleotide acting in the same way as in the CNS is a matter of interest. In this sense, it has been demonstrated in New Zealand white rabbits that the chemical destruction by means of 6-OHdopamine or reserpine, clearly eliminates sympathetic terminals altering the control of IOP among other processes. In this sense, subconjunctival injections of 6-OHDA cause sympatholysis with a sharp fall in IOP. Also a clear miosis has been observed as a consequence of the chemical denervation together with a loss of ocular sympathetic reflexes and a sharp reduction in the labelling of intraocular sympathetic neurons (Hoyle and Pintor, 2010) .
On a preliminary study on the possible effect of diadenosine tetraphosphate protecting the nervous system, the application of 100 mM Ap 4 A three days before the treatment with 6-OH dopamine or reserpine and 2 more days after the chemical denervation, preserved the sympathetic terminals present in the ciliary body from chemical denervation and therefore rabbits IOP did not fall as happens in the absence of the dinucleotide (Hoyle and Pintor, 2010) . This effect is quite unusual, since the nucleotide ATP and the nucleoside adenosine were totally unable to mimic Ap 4 A protective effect. Although adenosine acts via its own receptors, ATP and Ap 4 A should use common P2 receptors (Pintor and MirasPortugal, 1995b) . P2Y 2 receptors have been described in the ciliary body in New Zealand white rabbits . Nevertheless, and according to its pharmacology, both ATP and Ap 4 A should activate this receptor the final effect being the same, which is not the case. It could be the case that a selective receptor for diadenosine polyphosphates and not activated by ATP could be the one producing this protective effect Miras-Portugal, 1995a, 2000) . To date this is the only evidence for a selective dinucleotide receptor in the eye and more research is needed to confirm its real existence.
The way the dinucleotide Ap 4 A is protecting the ciliary body against 6-OH dopamine has not been clarified to date. One possibility is that the P2 receptor activated by Ap 4 A may induce the down-regulation (internalization) of the monomine transporter. This has been described for other transporters such as the dopamine transporter in the CNS (Xie and Miller, 2009) . The involvement of P2Y receptors inhibiting transporters has already been described and moreover, this process has been shown to occur via protein kinase C-dependent mechanism (Sen et al., 1993 ). An alternative possibility is that Ap 4 A stimulates a receptor connected to protection by limiting the negative effect of excessive reactive oxygen species. It could be the case that Ap 4 A may have an indirect effect protecting neurons against free radical damage. Melatonin has been shown to protect against 6-OHDA ( Dabbeni-Sala et al., 2001) , and it is an intriguing possibility that Ap 4 A can stimulate the release of melatonin from intraocular epithelium where it is synthesised (Zmijewski et al., 2009 One of the eye parts in which the research is weaker concerning dinucleoside polyphosphates is the retina. The presence of P2 receptors that might be stimulated by dinucleotides is broad in retinal cells, nevertheless, apart from the dinucleotide effect on retinal detachments, it is only possible to establish speculations about the actions of these compounds by means of such receptors.
Some therapeutic actions involve dinucleoside polyphosphates in relevant pathological states of the retina such as retinal detachment. Receptors for nucleotides in the retinal pigmented epithelium were described in the late 90's (Peterson et al., 1997; Sullivan et al., 1997) , mostly P2Y 2 suitable for dinucleotide activation . This fact made some researchers develop studies on animal models which were submitted to retinal detachment. In these models it was possible to demonstrate that some dinucleoside polyphosphates such as deoxycytidine tetraphospho uridine, also known as INS37217, or denufosol, was able to re-absorb the bleb between RPE and the neural retina in a very efficient way . This dinucleotide (INS37217), which is a P2Y 2 agonist, significantly enhanced subretinal fluid reabsorption when compared with vehicle controls (Maminishkis et al., 2002; Meyer et al., 2002; Nour et al., 2003) . One positive aspect is that INS37217 had no adverse effects on electroretinograms. In this sense, both scotopic and photopic ERG amplitudes and latency parameters remained stable when INS37217 was applied, this being a beneficial aspect to take into account (Meyer et al., 2002) . Other authors, on the contrary, indicate that subretinal injections of saline containing INS37217 significantly increased rod and cone ERG of normal and rds (±) mice at 1 and 10 days post-injections, when compared with injection of saline alone (Nour et al., 2003) . These experiments indicate that the dinucleotide INS37217 enhances ERG recovery probably by reducing retinal folding permitting reattachment.
It is important to note that the experiments performed with this dinucleotide demonstrated an increase in fluid absorption not only in animal models but also in freshly isolated bovine and fetal human RPE monolayers (Maminishkis et al., 2002) , and therefore the molecules would be a good candidate for the treatment of retinal detachments. Nevertheless, it is not all good news. There are two main handicaps in these studies; first, denufosol in some cases, to develop its action, needs to be used at high concentrations (around 1 mM) (Meyer et al., 2002) , which may produce the re-absorption process but presumably also the activation of many other P2 receptors due to the high concentrations of the dinucleotide. Second, in order to act it is necessary to be applied by means of intravitreal injections (Maminishkis et al., 2002; Meyer et al., 2002; Nour et al., 2003) .
Presence in other posterior structures
As discussed above, diadenosine polyphosphates and other nucleotides could activate metabotropic and ionotropic receptors described in mammalian retina (Cowlen et al., 2003; Franke et al., 2005; Fries et al., 2004; Greenwood et al., 1997; Kaneda et al., 2008; Notomi et al., 2011; Peterson et al., 1997; Pintor et al., 2004b; Fletcher, 2004, 2007; Shigematsu et al., 2007; Ward et al., 2008; Wheeler-Schilling et al., 2000 , 2001 . Numerous studies indicate a wide distribution of purinergic receptors throughout the different layers of retina. It can be suggested the possible effects of dinucleotides on P2 receptors and their potential physiological roles.
The activation of purinergic receptors through nucleotides and dinucleotides, such as diadenosine polyphosphates, may be implicated in embryo development and retinal precursor cell proliferation due to the implication of P2 receptors described in early neural retina (Sugioka et al., 1999) . Transcriptional regulation changes of these receptors during the development clearly indicate the relevant endogenous nucleotides participation.
Although both P2X and P2Y receptors have been observed in several neuronal populations including photoreceptors, amacrine and ganglion cells, recent studies suggest the implication of P2X receptors in the modulation of visual neurotransmission activity (Kaneda et al., 2008; Fletcher, 2004, 2007; Puthussery et al., 2006; Vessey and Fletcher, 2012) and the presumable involvement of diadenosine polyphosphates. Moreover, it could be contributing to the shedding of photoreceptor outer segments via P2Y receptors.
Furthermore, nucleotides serve as vasoactive signals in the pericyte-containing microvasculature of the retina. Different studies suggest nucleotides-induced increase in calcium levels and cellular contraction (Kawamura et al., 2003; Sugiyama et al., 2006) . In this sense, dinucleotides polyphosphates may contribute to regulate capillary function in retina. Moreover, P2X7 receptor activation triggered pericyte apoptosis that may be improved by P2Y 4 inhibition (Sugiyama et al., 2006) . For that action, ATP, diadenosine polyphosphates and other nucleotides balance have particular relevance in the environmental extracellular modulation and the concomitant activation of P2 receptors. Apart from pericytes it is also important to take into consideration the contribution of choroid in the retinal circulation. In this sense, it is important to consider the role of nucleotides and dinucleotides due to their relevant participation in vasoactive signals in the retinal vasculature including choriocapillaris and choroidal vasculature. Several authors have observed ATP action modifying ionic currents leading contractions of pericytes as previously commented (Kawamura et al., 2003) and apoptosis processes via P2X7 receptor activation. Moreover the dinucleotide concentration in blood should also modify endothelial cells by means of P2Y 2 receptors (Flores et al., 1999) facilitating vasodilation and therefore changing the retinal physiology.
Some of these functional implications may possibly be mediated by dinucleoside polyphosphates co-stored with ATP and classical neurotransmitters. In fact, the presence of ATP and Ap 4 A levels observed in stimulated retinas indicate the importance of these molecules in neurotransmission process (Dr. Perez de Lara, personal communication).
Finally, the presence of nucleotides in retinal glial cells could be responsible for the maintenance of homeostasis regulation for suitable functioning of the neural retina, among others. The molecular cloning and functional characterization of different families of ectoenzymes capable of hydrolyzing ATP, diadenosine polyphosphates and other nucleotides point to the relevance of this complex balance maintenance. Extracellular concentration of dinucleotides or their metabolites at retinal level are regulated by ecto-nucleotidases, nucleoside transporters and enzymes of adenosine metabolism. Neural retina, but also retinal pigment epithelium, expresses ecto-enzymes including NPP1 (described in Müller cells, the major glial component of the retina), NTPDase 2 (also expressed in Müller cells) and eN/5NTE (located on photoreceptors, Müller cells and retinal pigment epithelium) (Iandiev et al., 2007; Reigada et al., 2006; Takizawa, 1998; Wurm et al., 2010) .
Again, retinal structures possess several purinergic receptors and thus, the response of their cells depends on dinucleotides and also on their metabolites, mainly ATP and adenosine . Furthermore, adenosine effects in retina may be regulated by equilibrative (ENT1 and ENT2) and concentrative nucleoside transporters (CNT2 and CNT3) as well as adenosine deaminase 2 (ADA2) (Akanuma et al., 2013; dos Santos-Rodrigues et al., 2011; Elsherbiny et al., 2013; Nagase et al., 2006) . In fact, patients with diabetes express a high level of ADA2, which impaired the antiinflammatory activity of adenosine at retina level (Elsherbiny et al., 2013) .
Other relevant aspect that needs to be taken into consideration is the possible role of dinucleoside polyphosphates ameliorating retinal neuropathy. On the one hand, it has been described that the activation of some P2 receptors such as P2Y 2 (Nour et al., 2003; Maminishkis et al., 2002) and P2Y 13 (Perez-Sen et al., 2015) may be involved in neuroprotection processes mediated by MAPK pathway in the retina. Moreover, the exacerbated activity of ectoenzymes (NPPs) in pathological conditions may also contribute to this process, but more work is necessary to confirm the implication of ectonucleotidases on retinal impairment.
Conclusions and future directions
The participation of dinucleoside polyphosphates in ocular physiology opens the possibility of using these compounds for the treatment of relevant eye pathologies. Beginning with the ocular surface to the retina, the application of these dinucleotides may help to improve several processes, which may be altered in the pathology.
Dry eye is treated in some countries such as Japan and South Korea by means of the dinucleotides Up 4 U. This nucleotide can clearly increase tear secretion, both the aqueous and the mucin components. This is the only dinucleoside polyphosphate that is commercially available as a pharmaceutical compound. None of the others have moved to a clinical study as a previous step to commercialization. Nonetheless, many of the actions, mostly diadenosine polyphosphates do present very promising aspects from a therapeutic point of view as has been commented.
The advance in research needs some changes in order to be more successful in the search for dinucleotides as therapeutic agents. On the one hand, most of the compounds tested in their ability to counteract some of the pathological situations already described, have the characteristics of being fully degradable by ectonucleotidases (NPPs) therefore limiting their real effects (Asensio et al., 2007) . In this sense it would be of interest to develop some compounds resistant to the hydrolysis. The best way to protect these compounds from cleavage consists of substituting the ester bonds between the phosphates by methylene or amino groups. This has been done by some researchers (Biriukov et al., 1987) although it has not been tested if they improve the efficacy of the dinucleotides already tested in the eye (Chan et al., 1997) . This is an area of interest that deserves work because it may indicate that lower concentrations can produce the same or even better effects. On the other hand, it is very probable that by introducing such changes it may be possible to synthesize dinucleoside polyphosphates to become more selective to some receptors. Selectivity would permit us to reach specific targets without affecting other processes. It is important to be aware that, for example, a dinucleotide such as Ap 4 A can act on several P2 receptors Miras-Portugal, 1995b, 2000) , and therefore it would be able to stimulate all of them while it could be the case that only a particular subtype is needed to be activated. In this sense, hydrolysis resistant and selective dinucleotides are necessary to produce better, more selective and long-term effects.
Another important aspect that deserves attention is the delivery of the dinucleotides to internal parts of the eye. It is clear that actions on the ocular surface are obtained by topical applications of the given dinucleotides. Nonetheless, it is important to note that intraocular actions implies the delivery through the cornea, and this may reduce the availability of the dinucleotides in the aqueous humour and in the inner structures. The use of carriers such as liposomes is a possibility, although to our knowledge, no one has tested dinucleotides with vehicles like those. Interestingly, it has been indicated that some dinucleotides such as Ap 4 A, when applied on the ocular surface can temporarily open corneal epithelial tightjunctions (Loma et al., 2015b) facilitating the entry of compounds within the eye (Loma et al., 2015a) . This means that those actions carried out by dinucleoside polyphosphates in the inner eye may be enhanced if the application of the dinucleotide, Ap 4 A, is applied two hours previously. It is necessary to investigate this since, if the entry of the dinucleotide is improved it is possible that it may reach very deep areas of the eye.
In conclusion, dinucleoside polyphosphates are involved in a multitude of physiological processes which are relevant for the correct functioning of the eye. There are many promising perspectives using some of these compounds from a therapeutic point of view, however it is clear that new synthetic analogues of these dinucleotides are necessary to fully develop a battery of pharmaceutical compounds suitable for ocular therapy.
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